pkppvp治疗骨质疏松性椎体骨折的临床疗效分析

《pkppvp治疗骨质疏松性椎体骨折的临床疗效分析》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、PKPPVP治疗骨质疏松性椎体骨折的临床疗效分析株洲市中心医院湖南株洲412000【摘要】目的：探讨经皮椎体后凸成形术(PKP)/经皮椎体成形术(PVP)治疗骨质疏松性椎体骨折的临床疗效。方法：收集我院2014年7月~2015年7月间收治的骨质疏松性椎体骨折患者98例，采用随机数字表法将98例骨质疏松性椎体骨折患者分为实验组(n=58)及常规组(n=40),常规组患者行PVP手术治疗，实验组患者行PKP手术治疗。采用VAS评分评价两组患者术前、术后一周疼痛程度。两组患者均于治疗前及治疗1年后拍胸腰段正侧位X线片，测量责任椎前缘高度。结果：两组患者

2、术前及术后一周疼痛程度VAS评分比较，差异无统计学意义(P>；0.05)o实验组术后一年责任椎前缘高度明显高于常规组，差异有统计学意义(P<0.05)。结论：通过PKP手术治疗骨质疏松性椎体骨折，可有效的改善患者的疼痛程度，提高患者责任椎前缘高度，进一步改善患者的预后水平，值得推广。【关键词】经皮椎体后凸成形术；骨质疏松性椎体骨折；责任椎前缘高度[Abstract]Objective：Discussionoftheprotrudingafterpercutaneousvertebralplasty(PKPholds)/percutane

3、ousvertebralplasty(PVP)theclinicalcurativeeffectoftreatmentofosteoporoticvertebralfractures.Methods：98casesofpatientswithosteoporoticvertebralbodyinourhospitalfromJuly2014〜2015yearinJulyfromfracture,randomly98casesofosteoporoticvertebralfracturesweredividedintoexperimentalgro

4、up(n=58)androutinegroup(n=40),theroutinegroupweretreatedwithPVPsurgery,theexperimentalgroupweretreatedwithPKPsurgery.VASscorewasusedtoevaluatethedegreeofpainofthetwogroupsbeforeandaftertheoperation.Twogroupsofpatientsinthetreatmentandafter1yearsofmakingthoracolumbarlateralX-r

5、aymeasurementbeforetreatment,theresponsibilityofvertebralheight.Results：therewasnosignificantdifferenceinVASscoresbetweenthetwogroupsbeforeandoneweekaftertheoperation(P>0.05).Intheexperimentalgroup，oneyearaftertheoperation，theheightoftheleadingedgeofthevertebralbodywassign

6、ificantlyhigherthanthatoftheconventionalgroup,thedifferencewasstatisticallysignificant(P<0.05)•Conclusion：PKPsurgeryinthetreatmentofosteoporoticvertebralfracture，caneffectivelyimprovethepatient'sdegreeofpain，improvetheheightofpatients1responsibilityofvertebralheight,andfur

7、therimprovetheprognosisofpatients，itisworthpromoting.［Keywords］percutaneouslumbarvertebralbodyfracture；osteoporoticvertebralfracture骨质疏松性椎体骨折为骨科中较为常见的骨折类型，尤苏以老年人发病率较高［1-2］。我院采用PKP与PVP治疗对骨质疏松性椎体骨折患者进行治疗，探讨PKP对患者骨折的疗效。现报道如下。1资料与方法1.1一般资料收集我院2014年7月~2015年7月间收治的骨质疏松性椎体骨折患者98例，纳入标

8、准：所奋患者经影像学检查均符合骨质疏松性椎体骨折诊断标准［3］，所有患者均签署知情同意书。排除标准：并发恶性疾病消耗体能较大者；拒绝参与